KUKJEON PHARMACEUTICAL Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	7,054	10,992	21,546	19,099
Short-Term Investments	10,000	15,000	45,000	20,160
Trading Asset Securities	35,354	38,840	28,425	-
Cash & Short-Term Investments	52,408	64,833	94,971	39,259
Cash Growth	-14.78%	-31.73%	141.91%	-
Accounts Receivable	33,028	26,850	21,923	20,015
Other Receivables	342.82	1,964	867.93	194.62
Receivables	33,691	29,065	23,403	20,409
Inventory	25,832	27,563	20,209	16,207
Prepaid Expenses	393.88	494.91	246.48	143.8
Other Current Assets	1,272	2,036	4,064	896.09
Total Current Assets	113,596	123,992	142,893	76,915
Property, Plant & Equipment	89,110	86,060	46,118	24,026
Long-Term Investments	3,902	4,364	3,173	3,493
Goodwill	420.39	420.39	420.39	-
Other Intangible Assets	909.41	971	903.51	422.37
Long-Term Deferred Tax Assets	1,861	1,964	-	794.9
Other Long-Term Assets	7,180	7,090	2,379	517.79
Total Assets	220,699	225,102	196,097	106,989
Accounts Payable	16,797	11,693	9,474	10,989
Accrued Expenses	326.62	289.73	178.99	83.02
Short-Term Debt	7,904	15,224	7,883	5,133
Current Portion of Long-Term Debt	41,255	36,802	26,015	1,457
Current Portion of Leases	281.87	236.17	147.15	124.88
Current Income Taxes Payable	-	-	-	1,057
Current Unearned Revenue	17.58	35.16	-	-
Other Current Liabilities	28,166	35,542	26,993	3,007
Total Current Liabilities	94,748	99,823	70,691	21,852
Long-Term Debt	24,447	26,183	25,091	942.84
Long-Term Leases	367.55	334.14	202.84	193.97
Long-Term Deferred Tax Liabilities	10.45	10.45	1,365	-
Other Long-Term Liabilities	1,271	1,296	6,425	849.76
Total Liabilities	120,844	127,646	103,774	23,838
Common Stock	4,907	4,907	4,907	4,907
Additional Paid-In Capital	62,139	62,386	62,386	62,397
Retained Earnings	32,148	29,129	24,305	15,848
Treasury Stock	-1.16	-1.16	-1.16	-1.16
Comprensive Income & Other	-0	0	0	0
Total Common Equity	99,193	96,422	91,597	83,150
Minority Interest	662.31	1,035	725.74	-
Shareholders' Equity	99,855	97,456	92,323	83,150
Total Liabilities & Equity	220,699	225,102	196,097	106,989
Total Debt	74,256	78,780	59,339	7,852
Net Cash (Debt)	-21,848	-13,947	35,632	31,407
Net Cash Growth	-	-	13.45%	-
Net Cash Per Share	-402.33	-284.24	695.44	712.02
Filing Date Shares Outstanding	49.07	49.07	49.07	49.07
Total Common Shares Outstanding	49.07	49.07	49.07	49.07
Working Capital	18,847	24,169	72,202	55,063
Book Value Per Share	2021.49	1965.01	1866.70	1694.56
Tangible Book Value	97,863	95,030	90,274	82,728
Tangible Book Value Per Share	1994.39	1936.66	1839.72	1685.95
Land	20,224	19,837	15,613	3,997
Buildings	37,365	36,673	11,300	8,252
Machinery	29,887	22,297	11,051	7,554
Construction In Progress	623.29	6,407	13,388	9,214

Source: S&P Capital IQ. Standard template. Financial Sources.